Obstructive sleep apnea, immuno-inflammation, and atherosclerosis

Seminars in Immunopathology

Volumn 31, Issue 1, 2009, Pages 113-125

  Arnaud, Claire ^a,b   Dematteis, Maurice ^a,b,c   Pepin, Jean Louis ^a,b,c   Baguet, Jean Philippe ^b,d   Lévy, Patrick ^a,b,c  

^a INSERM   (France)

^b UNIV GRENOBLE ALPES   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d HÔPITAL MICHALLON   (France)

Author keywords

Adipose tissue; Atherosclerosis; Chemokines; Inflammation; Intermittent hypoxia; Obstructive sleep apnea

Indexed keywords

ADIPOCYTOKINE; LIPID;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONOLOGY; COMORBIDITY; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; GENETIC SUSCEPTIBILITY; HEMODYNAMICS; HUMAN; HYPOXIA; INFLAMMATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID METABOLISM; METABOLISM; NONHUMAN; OXIDATIVE STRESS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SLEEP APNEA SYNDROME; VASOCONSTRICTION;

EID: 67749117816     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-009-0148-5     Document Type: Review

References (161)

1. A Malhotra DP White 2002 Obstructive sleep apnoea Lancet 360 9328 237 245 10.1016/S0140-6736(02) 09464-3
2. VK Somers 2008 Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health) Circulation 118 10 1080 1111 10.1161/CIRCULATIONAHA.107.189420
3. P Mayer 1996 Relationship between body mass index, age and upper airway measurements in snorers and sleep apnoea patients Eur Respir J 9 9 1801 1809 10.1183/09031936.96.09091801
4. DP White 2005 Pathogenesis of obstructive and central sleep apnea Am J Respir Crit Care Med 172 11 1363 1370 10.1164/rccm.200412-1631SO (Pubitemid 43069808)
5. RL Horner 2007 Contributions of passive mechanical loads and active neuromuscular compensation to upper airway collapsibility during sleep J Appl Physiol 102 2 510 512 10.1152/japplphysiol.01213.2006 (Pubitemid 46220876)
6. P Levy 2008 Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives Eur Respir J 32 4 1082 1095 10.1183/09031936.00013308
7. T Young 1993 The occurrence of sleep-disordered breathing among middle-aged adults N Engl J Med 328 17 1230 1235 10.1056/NEJM199304293281704 (Pubitemid 23115702)
8. T Young PE Peppard DJ Gottlieb 2002 Epidemiology of obstructive sleep apnea: a population health perspective Am J Respir Crit Care Med 165 9 1217 1239 10.1164/rccm.2109080 (Pubitemid 34461732)
9. J Teran-Santos A Jimenez-Gomez J Cordero-Guevara 1999 The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander N Engl J Med 340 11 847 851 10.1056/NEJM199903183401104 (Pubitemid 29142628)
10. S Mazza 2002 Analysis of error profiles occurring during the OSLER test: a sensitive mean of detecting fluctuations in vigilance in patients with obstructive sleep apnea syndrome Am J Respir Crit Care Med 166 4 474 478 10.1164/rccm.2107065 (Pubitemid 34895431)
11. JM Marin 2005 Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study Lancet 365 9464 1046 1053
12. JC Pepperell 2002 Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial Lancet 359 9302 204 210 10.1016/S0140- 6736(02)07445-7 (Pubitemid 34113817)
13. HK Yaggi 2005 Obstructive sleep apnea as a risk factor for stroke and death N Engl J Med 353 19 2034 2041 10.1056/NEJMoa043104 (Pubitemid 41609096)
14. VK Somers 2008 Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing J Am Coll Cardiol 52 8 686 717 10.1016/j.jacc.2008.05.002
15. T Young 2008 Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort Sleep 31 8 1071 1078
16. JP Baguet 2005 The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence Chest 128 5 3407 3412 10.1378/chest.128.5.3407 (Pubitemid 41698671)
17. K Minoguchi 2005 Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea Am J Respir Crit Care Med 172 5 625 630 10.1164/rccm.200412-1652OC (Pubitemid 41232975)
18. LF Drager 2005 Early signs of atherosclerosis in obstructive sleep apnea Am J Respir Crit Care Med 172 5 613 618 10.1164/rccm.200503-340OC (Pubitemid 41232973)
19. J Turmel 2009 Relationship between atherosclerosis and the sleep apnea syndrome: an intravascular ultrasound study Int J Cardiol 132 2 203 209 10.1016/j.ijcard.2007.11.063
20. RC Basner 2007 Continuous positive airway pressure for obstructive sleep apnea N Engl J Med 356 17 1751 1758 10.1056/NEJMct066953 (Pubitemid 46661544)
21. C Jenkinson 1999 Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial Lancet 353 9170 2100 2105 10.1016/S0140-6736(98) 10532-9 (Pubitemid 29278478)
22. JM Montserrat 2001 Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome. A randomized controlled study with an optimized placebo Am J Respir Crit Care Med 164 4 608 613
23. P Haentjens 2007 The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials Arch Intern Med 167 8 757 764 10.1001/archinte.167.8.757 (Pubitemid 46658332)
24. P Lévy 2009 Obstructive sleep apnea and atherosclerosis Prog Cardiovasc Dis 51 5 400 410 10.1016/j.pcad.2008.03.001
25. P Gay 2006 Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults Sleep 29 3 381 401
26. JL Pepin 1999 Effective compliance during the first 3 months of continuous positive airway pressure. A European prospective study of 121 patients Am J Respir Crit Care Med 160 4 1124 1129
27. TE Weaver 2007 Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning Sleep 30 6 711 719
28. IA Harsch 2004 Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome Am J Respir Crit Care Med 169 2 156 162 10.1164/rccm.200302-206OC (Pubitemid 38114528)
29. SR Coughlin 2007 Cardiovascular and metabolic effects of CPAP in obese males with OSA Eur Respir J 29 4 720 727 10.1183/09031936.00043306 (Pubitemid 46554622)
30. SD West 2007 Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes Thorax 62 11 969 974 10.1136/thx.2006.074351 (Pubitemid 350084496)
31. Dematteis M et al. (2009) Cardiovascular consequences of sleep disordered breathing: contribution of animal models to understanding the human disease. ILAR J 50(3)
32. RJ Kimoff 1994 Canine model of obstructive sleep apnea: model description and preliminary application J Appl Physiol 76 4 1810 1817
33. D Brooks 1997 Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model J Clin Invest 99 1 106 109 10.1172/JCI119120 (Pubitemid 27058300)
34. M Nacher 2007 Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea Respir Physiol Neurobiol 155 1 93 96 10.1016/j.resp. 2006.06.004
35. JA Neubauer 2001 Invited review: physiological and pathophysiological responses to intermittent hypoxia J Appl Physiol 90 4 1593 1599
36. EC Fletcher 2001 Invited review: physiological consequences of intermittent hypoxia: systemic blood pressure J Appl Physiol 90 4 1600 1605
37. BJ Morgan 2007 Vascular consequences of intermittent hypoxia Adv Exp Med Biol 618 69 84 10.1007/978-0-387-75434-5-6
38. NR Prabhakar 2001 Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms J Appl Physiol 90 5 1986 1994
39. L Dyugovskaya P Lavie L Lavie 2002 Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients Am J Respir Crit Care Med 165 7 934 939
40. S Ryan CT Taylor WT McNicholas 2005 Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome Circulation 112 17 2660 2667 10.1161/CIRCULATIONAHA.105.556746 (Pubitemid 41532603)
41. GK Hansson 2005 Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 16 1685 1695 10.1056/NEJMra043430 (Pubitemid 40530235)
42. P Libby 2002 Inflammation in atherosclerosis Nature 420 6917 868 874 10.1038/nature01323 (Pubitemid 36019640)
43. AJ Lusis 2000 Atherosclerosis Nature 407 6801 233 241 10.1038/35025203
44. PE Peppard 2000 Prospective study of the association between sleep-disordered breathing and hypertension N Engl J Med 342 19 1378 1384 10.1056/NEJM200005113421901 (Pubitemid 30262394)
45. D Brooks 1997 Effect of obstructive sleep apnea versus sleep fragmentation on responses to airway occlusion Am J Respir Crit Care Med 155 5 1609 1617 (Pubitemid 27216666)
46. ML Smith CF Pacchia 2007 Sleep apnoea and hypertension: role of chemoreflexes in humans Exp Physiol 92 1 45 50 10.1113/expphysiol.2006.033753 (Pubitemid 46096253)
47. VK Somers 1995 Sympathetic neural mechanisms in obstructive sleep apnea J Clin Invest 96 4 1897 1904 10.1172/JCI118235
48. M Dematteis 2008 Intermittent hypoxia induces early functional cardiovascular remodeling in mice Am J Respir Crit Care Med 177 2 227 235 10.1164/rccm.200702-238OC
49. YS Chatzizisis 2007 Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior J Am Coll Cardiol 49 25 2379 2393 10.1016/j.jacc.2007.02.059 (Pubitemid 46962266)
50. M Kato 2000 Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea Circulation 102 21 2607 2610
51. H Kraiczi 2001 Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep Chest 119 4 1085 1091 10.1378/chest.119.4.1085 (Pubitemid 32679435)
52. VA Imadojemu 2002 Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy Am J Respir Crit Care Med 165 7 950 953
53. VA Imadojemu 2002 Obstructive apnea during sleep is associated with peripheral vasoconstriction Am J Respir Crit Care Med 165 1 61 66
54. Z Tahawi 2001 Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats J Appl Physiol 90 5 2007 2013 discussion 2000
55. SA Phillips 2004 Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries Am J Physiol Heart Circ Physiol 286 1 H388 H393 10.1152/ajpheart.00683. 2003
56. B Lefebvre 2006 Functional assessment of vascular reactivity after chronic intermittent hypoxia in the rat Respir Physiol Neurobiol 150 2-3 278 286 10.1016/j.resp. 2005.05.020
57. MS Ip 2000 Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure Am J Respir Crit Care Med 162 6 2166 2171
58. L Lavie 2003 Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatment J Mol Neurosci 21 1 57 63 10.1385/JMN:21:1:57 (Pubitemid 37204873)
59. S Teramoto 2003 Oxygen administration improves the serum level of nitric oxide metabolites in patients with obstructive sleep apnea syndrome Sleep Med 4 5 403 407 10.1016/S1389-9457(03)00102-3 (Pubitemid 37193023)
60. Y Ohike 2005 Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure-possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine Circ J 69 2 221 226 10.1253/circj.69.221 (Pubitemid 40313045)
61. HW Duchna 2005 Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome Sleep Breath 9 3 97 103 10.1007/s11325-005-0024-z (Pubitemid 44193439)
62. JL Lattimore 2006 Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation Thorax 61 6 491 495 10.1136/thx.2004.039164 (Pubitemid 43901518)
63. A Noda 2007 Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome Hypertens Res 30 8 669 676 10.1291/hypres.30.669 (Pubitemid 47517099)
64. Y Ozkan 2008 Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS) Sleep Breath 12 2 149 154 10.1007/s11325-007-0148-4
65. RP Mason 2006 Nitric oxide mechanisms in the pathogenesis of global risk J Clin Hypertens (Greenwich) 8 8 Suppl 2 31 38 10.1111/j.1524-6175.2006.05838.x quiz 40
66. E Belaidi 2009 Major role for HIF-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea J Am Coll Cardiol 53 15 1309 1317
67. MJ Mulvany 1996 Vascular remodeling Hypertension 28 3 505 506
68. LF Drager 2007 Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea Am J Respir Crit Care Med 176 7 706 712 10.1164/rccm.200703-500OC (Pubitemid 47503079)
69. Arnaud C et al. (2008) Intermittent hypoxia induces inflammatory vascular remodeling in C57bl6 mice. In: American Thoracic Society 2008 International Conference. Am J Resp Crit Care Med 177, Meeting abstracts, 2008, Toronto, Canada
70. Belaidi E et al. (2008) Dual endothelin-1 receptor antagonism prevents chronic intermittent hypoxia-induced cardiovascular alterations in rat. In: European Respiratory Society 2008 International Conference. Eur Resp J 32(suppl 52), Meeting abstract, 2008, Berlin, Germany
71. Arnaud C et al. (2009) Intermittent hypoxia induces inflammatory vascular and myocardial remodeling: role of the endothelin system. In: American Thoracic Society 2009 International Conference. Am J Respir Crit Care Med 179, Meeting Abstracts, 2009, San Diego, USA
72. KJ Allahdadi BR Walker NL Kanagy 2005 Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension Hypertension 45 4 705 709 10.1161/01.HYP.0000153794.52852.04 (Pubitemid 40418369)
73. B Lefebvre 2008 Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea? Eur Respir J 32 1 113 120 10.1183/09031936.00137107
74. MJ Chapman AC Sposito 2008 Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy Pharmacol Ther 117 3 354 373 10.1016/j.pharmthera.2007.10.004
75. AB Newman 2005 Progression and regression of sleep-disordered breathing with changes in weight: the sleep heart health study Arch Intern Med 165 20 2408 2413 10.1001/archinte.165.20.2408 (Pubitemid 41640854)
76. N Peled 2007 The association of OSA with insulin resistance, inflammation and metabolic syndrome Respir Med 101 8 1696 1701 10.1016/j.rmed.2007.02.025 (Pubitemid 46947878)
77. M Kono 2007 Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome Chest 131 5 1387 1392 10.1378/chest.06-1807 (Pubitemid 46762343)
78. N Meslier 2003 Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome Eur Respir J 22 1 156 160 10.1183/09031936.03. 00089902 (Pubitemid 36896486)
79. KP Strohl 1994 Insulin levels, blood pressure and sleep apnea Sleep 17 7 614 618
80. AN Vgontzas 2000 Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia J Clin Endocrinol Metab 85 3 1151 1158 10.1210/jc.85.3.1151 (Pubitemid 32269364)
81. MS Ip 2002 Obstructive sleep apnea is independently associated with insulin resistance Am J Respir Crit Care Med 165 5 670 676
82. N McArdle 2007 Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study Am J Respir Crit Care Med 175 2 190 195 10.1164/rccm.200602-270OC (Pubitemid 46115091)
83. NM Punjabi 2002 Sleep-disordered breathing and insulin resistance in middle-aged and overweight men Am J Respir Crit Care Med 165 5 677 682
84. RA Stoohs F Facchini C Guilleminault 1996 Insulin resistance and sleep-disordered breathing in healthy humans Am J Respir Crit Care Med 154 1 170 174
85. SK Sharma 2007 Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing Sleep Med 8 1 12 17 10.1016/j.sleep. 2006.06.014
86. A Barcelo 2008 Insulin resistance and daytime sleepiness in patients with sleep apnoea Thorax 63 11 946 950 10.1136/thx.2007.093740
87. VY Polotsky 2009 Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity Am J Respir Crit Care Med 179 3 228 234 10.1164/rccm.200804-608OC
88. R Muniyappa 2007 Cardiovascular actions of insulin Endocr Rev 28 5 463 491 10.1210/er.2007-0006 (Pubitemid 47236334)
89. J Nigro 2006 Insulin resistance and atherosclerosis Endocr Rev 27 3 242 259 10.1210/er.2005-0007
90. VY Polotsky 2003 Intermittent hypoxia increases insulin resistance in genetically obese mice J Physiol 552 Pt 1 253 264 10.1113/jphysiol.2003.048173 (Pubitemid 37265483)
91. SS Martin A Qasim MP Reilly 2008 Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease J Am Coll Cardiol 52 15 1201 1210 10.1016/j.jacc.2008.05.060
92. L Dubey Z Hesong 2006 Role of leptin in atherogenesis Exp Clin Cardiol 11 4 269 275
93. J Beltowski 2006 Leptin and atherosclerosis Atherosclerosis 189 1 47 60 10.1016/j.atherosclerosis.2006.03.003 (Pubitemid 44441296)
94. J Sierra-Johnson 2008 Effect of altitude on leptin levels, does it go up or down? J Appl Physiol 105 5 1684 1685 10.1152/japplphysiol.01284.2007
95. A Grosfeld 2002 Hypoxia-inducible factor 1 transactivates the human leptin gene promoter J Biol Chem 277 45 42953 42957 10.1074/jbc.M206775200 (Pubitemid 35285673)
96. A Barcelo 2005 Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity Am J Respir Crit Care Med 171 2 183 187 10.1164/rccm.200405-579OC (Pubitemid 40105419)
97. J Borgel 2006 Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels Eur Respir J 27 1 121 127 10.1183/09031936.06.00131304 (Pubitemid 43092675)
98. S Saarelainen J Lahtela E Kallonen 1997 Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin J Sleep Res 6 2 146 147
99. K Chin 1999 Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy Circulation 100 7 706 712
100. MS Ip 2000 Serum leptin and vascular risk factors in obstructive sleep apnea Chest 118 3 580 586 10.1378/chest.118.3.580
101. K Shimizu 2002 Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome Thorax 57 5 429 434 10.1136/thorax.57.5.429 (Pubitemid 34494154)
102. Y Okamoto 2006 Adiponectin: a key adipocytokine in metabolic syndrome Clin Sci (Lond) 110 3 267 278 10.1042/CS20050182 (Pubitemid 43341630)
103. O Gualillo JR Gonzalez-Juanatey F Lago 2007 The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives Trends Cardiovasc Med 17 8 275 283 10.1016/j.tcm.2007.09.005 (Pubitemid 350087698)
104. F Lago 2007 Adipokines as emerging mediators of immune response and inflammation Nat Clin Pract Rheumatol 3 12 716 724 10.1038/ncprheum0674 (Pubitemid 350187017)
105. S Makino 2006 Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance Clin Endocrinol (Oxf) 64 1 12 19 10.1111/j.1365-2265.2005.02407.x
106. F Tokuda 2008 Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome Intern Med 47 21 1843 1849 10.2169/internalmedicine.47.1035
107. R Wolk 2005 Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea Obes Res 13 1 186 190 10.1038/oby.2005.24
108. XL Zhang 2004 Serum adiponectin level in patients with obstructive sleep apnea hypopnea syndrome Chin Med J (Engl) 117 11 1603 1606
109. XL Zhang 2006 Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome Respiration 73 1 73 77 10.1159/000088690 (Pubitemid 43296242)
110. B Masserini 2006 Reduced levels of adiponectin in sleep apnea syndrome J Endocrinol Invest 29 8 700 705
111. XL Zhang 2007 Effect of continuous positive airway pressure treatment on serum adiponectin level and mean arterial pressure in male patients with obstructive sleep apnea syndrome Chin Med J (Engl) 120 17 1477 1481
112. Y Nakagawa 2008 Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome Am J Physiol Endocrinol Metab 294 4 E778 E784 10.1152/ajpendo.00709.2007
113. A Kanbay 2008 Comparison of serum adiponectin and tumor necrosis factor-alpha levels between patients with and without obstructive sleep apnea syndrome Respiration 76 3 324 330 10.1159/000134010
114. JC Lam 2008 Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea Sleep 31 12 1721 1727
115. B Chen 2006 Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes Biochem Biophys Res Commun 341 2 549 556 10.1016/j.bbrc.2006.01.004 (Pubitemid 43152139)
116. N Hosogai 2007 Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation Diabetes 56 4 901 911 10.2337/db06-0911 (Pubitemid 46525054)
117. B Wang IS Wood P Trayhurn 2007 Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes Pflugers Arch 455 3 479 492 10.1007/s00424-007-0301-8 (Pubitemid 47624196)
118. J Ye 2007 Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice Am J Physiol Endocrinol Metab 293 4 E1118 E1128 10.1152/ajpendo.00435.2007 (Pubitemid 47535846)
119. UJ Magalang 2008 Intermittent hypoxia suppresses adiponectin secretion by adipocytes Exp Clin Endocrinol Diabetes 117 129 134
120. Y Yamamoto 2008 Resistin is closely related to systemic inflammation in obstructive sleep apnea Respiration 76 4 377 385 10.1159/000141866
121. H Wu 2007 T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity Circulation 115 8 1029 1038 10.1161/CIRCULATIONAHA.106.638379 (Pubitemid 46328297)
122. S Thalmann CA Meier 2007 Local adipose tissue depots as cardiovascular risk factors Cardiovasc Res 75 4 690 701 10.1016/j.cardiores.2007.03.008 (Pubitemid 47238732)
123. E Henrichot 2005 Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol 25 12 2594 2599 10.1161/01.ATV.0000188508.40052.35 (Pubitemid 43732284)
124. HC McGill Jr 2002 Obesity accelerates the progression of coronary atherosclerosis in young men Circulation 105 23 2712 2718 10.1161/01.CIR. 0000018121.67607.CE (Pubitemid 34615140)
125. G Fantuzzi T Mazzone 2007 Adipose tissue and atherosclerosis: exploring the connection Arterioscler Thromb Vasc Biol 27 5 996 1003 10.1161/ATVBAHA.106. 131755 (Pubitemid 46641984)
126. MK Ohman 2008 Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice Circulation 117 6 798 805 10.1161/CIRCULATIONAHA.107.717595 (Pubitemid 351640681)
127. D Vela 2007 The role of periadventitial fat in atherosclerosis Arch Pathol Lab Med 131 3 481 487
128. AB Newman 2001 Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study Am J Epidemiol 154 1 50 59 10.1093/aje/154.1.50 (Pubitemid 32565686)
129. GV Robinson 2004 Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials Thorax 59 9 777 782 10.1136/thx.2003.018739 (Pubitemid 39215375)
130. L Lavie 2003 Obstructive sleep apnoea syndrome-an oxidative stress disorder Sleep Med Rev 7 1 35 51 10.1053/smrv.2002.0261 (Pubitemid 36188305)
131. KC Tan 2005 HDL dysfunction in obstructive sleep apnea Atherosclerosis 184 377 382
132. L Lavie A Vishnevsky P Lavie 2004 Evidence for lipid peroxidation in obstructive sleep apnea Sleep 27 1 123 128
133. J Li 2005 Intermittent hypoxia induces hyperlipidemia in lean mice Circ Res 97 7 698 706 10.1161/01.RES.0000183879.60089.a9 (Pubitemid 41416339)
134. J Li 2007 Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia J Appl Physiol 102 2 557 563 10.1152/japplphysiol.01081.2006 (Pubitemid 46220883)
135. JD Lattimore 2005 Repetitive hypoxia increases lipid loading in human macrophages-a potentially atherogenic effect Atherosclerosis 179 2 255 259 10.1016/j.atherosclerosis.2004.11.010 (Pubitemid 40364618)
136. V Savransky 2007 Chronic intermittent hypoxia induces atherosclerosis Am J Respir Crit Care Med 175 12 1290 1297 10.1164/rccm.200612-1771OC (Pubitemid 46905755)
137. V Savransky 2008 Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase Circ Res 103 10 1173 1180 10.1161/CIRCRESAHA.108.178533
138. WT McNicholas MR Bonsignore 2007 Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities Eur Respir J 29 1 156 178 10.1183/09031936.00027406 (Pubitemid 46092013)
139. GS Hotamisligil 2006 Inflammation and metabolic disorders Nature 444 7121 860 867 10.1038/nature05485 (Pubitemid 46024993)
140. AS Shamsuzzaman 2002 Elevated C-reactive protein in patients with obstructive sleep apnea Circulation 105 21 2462 2464 10.1161/01.CIR.0000018948. 95175.03 (Pubitemid 34568964)
141. T Yokoe 2003 Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure Circulation 107 8 1129 1134 10.1161/01.CIR.0000052627. 99976.18 (Pubitemid 36297204)
142. M Yao 2006 The relationship between sleep-disordered breathing and high-sensitivity C-reactive protein in Japanese men Sleep 29 5 661 665
143. S Taheri 2007 Correlates of serum C-reactive protein (CRP)-no association with sleep duration or sleep disordered breathing Sleep 30 8 991 996
144. C Guilleminault C Kirisoglu MM Ohayon 2004 C-reactive protein and sleep-disordered breathing Sleep 27 8 1507 1511
145. M Kohler 2009 Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial Thorax 64 1 67 73 10.1136/thx.2008.097931
146. GE Carpagnano 2002 Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients Chest 122 4 1162 1167 10.1378/chest.122.4.1162 (Pubitemid 35339525)
147. E Ohga 1999 Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome J Appl Physiol 87 1 10 14
148. E Ohga 2003 Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1 J Appl Physiol 94 1 179 184
149. R Schulz 2000 Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy Am J Respir Crit Care Med 162 2 Pt 1 566 570
150. L Dyugovskaya 2008 Delayed neutrophil apoptosis in patients with sleep apnea Am J Respir Crit Care Med 177 5 544 554 10.1164/rccm.200705-675OC
151. L Dyugovskaya 2005 Activated CD8+ T-lymphocytes in obstructive sleep apnoea Eur Respir J 25 5 820 828 10.1183/09031936.05.00103204 (Pubitemid 40667679)
152. L Dyugovskaya P Lavie L Lavie 2005 Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea Ann N Y Acad Sci 1051 340 350 10.1196/annals.1361.076 (Pubitemid 41362764)
153. JD van Buul PL Hordijk 2004 Signaling in leukocyte transendothelial migration Arterioscler Thromb Vasc Biol 24 5 824 833 10.1161/01.ATV.0000122854. 76267.5c (Pubitemid 38620858)
154. E Tzima 2005 A mechanosensory complex that mediates the endothelial cell response to fluid shear stress Nature 437 7057 426 431 10.1038/nature03952 (Pubitemid 41613506)
155. H Greenberg 2006 Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo Biochem Biophys Res Commun 343 2 591 596 10.1016/j.bbrc.2006.03.015
156. K Minoguchi 2004 Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome Chest 126 5 1473 1479 10.1378/chest.126.5.1473 (Pubitemid 39525019)
157. B Paigen 1985 Variation in susceptibility to atherosclerosis among inbred strains of mice Atherosclerosis 57 1 65 73 10.1016/0021-9150(85)90138-8 (Pubitemid 15247039)
158. JL Stewart-Phillips J Lough 1991 Pathology of atherosclerosis in cholesterol-fed, susceptible mice Atherosclerosis 90 2-3 211 218 10.1016/0021-9150(91)90117-L
159. MH Hofker BJ van Vlijmen LM Havekes 1998 Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis Atherosclerosis 137 1 1 11 10.1016/S0021-9150(97)00266-9 (Pubitemid 28175371)
160. Jun JC et al. (2008) Intermittent hypoxia accelerates aortic
161. Arnaud C et al. (2008) Chronic intermittent hypoxia accelerates atherosclerotic plaque formation in ApoE knockout mice independently of cholesterol levels. In: European Respiratory Society 2008 International Conference. Eur Resp J 32(suppl 52), Meeting abstract, 2008, Berlin, Germany.